- St. Jude Medical (NYSE:STJ +0.5%) Q4 results: Revenues: $1,447M (+0.6%); R&D Expense: $177M (+1.1%); SG&A: $588M (+28.7%); Operating Income: $97M (-65.4%); Net Income: $113M (-53.9%); EPS: $0.39 (-53.6%); Non-GAAP EPS: $1.02 (-5.6%).
- FY2015 results: Revenues: $5,541M (-1.4%); R&D Expense: $676M (-2.3%); SG&A: $1,878M (+1.2%); Operating Income: $1,030M (-10.5%); Net Income: $880M (-12.2%); EPS: $3.07 (-11.3%); Non-GAAP EPS: $3.94 (-5.5%); Quick Assets: $667M (-53.7%).
- Q1 Guidance: GAAP EPS: $0.68 - 0.70; Non-GAAP EPS: $0.87 - 0.89.
- 2016 Guidance: Revenues: $5.900B - 6.040B; GAAP EPS: $3.33 - 3.43; Non-GAAP EPS: $3.95 - 4.05.